肾功能不全对急性冠状动脉综合征患者早期侵入性治疗的影响（TACTICS-TIMI 18试验） - Suppr

Suppr

超能文献

Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial).

作者信息

Januzzi James L, Cannon Christopher P, DiBattiste Peter M, Murphy Sabina, Weintraub William, Braunwald Eugene

机构信息

Cardiology Division, Massachusetts General Hospital, Boston, Masssachusetts 02114, USA.

出版信息

Am J Cardiol. 2002 Dec 1;90(11):1246-9. doi: 10.1016/s0002-9149(02)02844-8.

DOI:10.1016/s0002-9149(02)02844-8

PMID:12450608

Abstract

摘要

相似文献

Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial).肾功能不全对急性冠状动脉综合征患者早期侵入性治疗的影响（TACTICS-TIMI 18试验）

Am J Cardiol. 2002 Dec 1;90(11):1246-9. doi: 10.1016/s0002-9149(02)02844-8.

Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction.替罗非班治疗后不稳定型心绞痛和非Q波心肌梗死的侵入性与保守策略：国际TACTICS-TIMI 18试验的原理和研究设计。用阿昔单抗治疗心绞痛并确定侵入性或保守策略的治疗成本。心肌梗死溶栓治疗。

Am J Cardiol. 1998 Sep 15;82(6):731-6. doi: 10.1016/s0002-9149(98)00540-2.

Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.上游糖蛋白IIb/IIIa抑制及冠状动脉支架置入术在不稳定型心绞痛/非ST段抬高型心肌梗死侵入性治疗中的意义：心肌梗死溶栓治疗（TIMI）IIIB试验与应用阿昔单抗治疗心绞痛并确定侵入性或保守性策略治疗费用（TACTICS）-TIMI 18试验的比较

Circulation. 2004 Feb 24;109(7):874-80. doi: 10.1161/01.CIR.0000112604.74713.35. Epub 2004 Feb 2.

Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.急性冠状动脉综合征经皮冠状动脉介入治疗期间阿昔单抗、替罗非班和依替巴肽对血小板抑制作用的随机对照研究：COMPARE试验。阿昔单抗、瑞替普酶和依替巴肽对血小板聚集测量的比较。

Circulation. 2002 Sep 17;106(12):1470-6. doi: 10.1161/01.cir.0000029744.01096.1f.

Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.

Circulation. 2002 May 21;105(20):2361-6. doi: 10.1161/01.cir.0000016359.94919.16.

Upstream use of tirofiban in patients admitted for an acute coronary syndrome in hospitals with or without facilities for invasive management. PRISM-PLUS Investigators.在有或没有侵入性治疗设施的医院中，急性冠脉综合征住院患者早期使用替罗非班。PRISM-PLUS研究组。

Am J Cardiol. 2001 Feb 15;87(4):375-80. doi: 10.1016/s0002-9149(00)01386-2.

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.使用糖蛋白IIb/IIIa抑制剂替罗非班治疗的不稳定型冠状动脉综合征患者早期侵入性策略与保守策略的比较

N Engl J Med. 2001 Jun 21;344(25):1879-87. doi: 10.1056/NEJM200106213442501.

Suboptimal inhibition of platelet aggregation following tirofiban bolus in patients undergoing percutaneous coronary intervention for unstable angina pectoris.在接受经皮冠状动脉介入治疗不稳定型心绞痛的患者中，替罗非班推注后血小板聚集抑制效果欠佳。

Am J Cardiol. 2003 Apr 1;91(7):872-5. doi: 10.1016/s0002-9149(03)00024-9.

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.一种预测替罗非班在非ST段抬高型急性冠状动脉综合征中获益的综合临床方法。TIMI非稳定性心绞痛/非ST段抬高型心肌梗死风险评分在PRISM-PLUS研究中的应用。

Eur Heart J. 2002 Feb;23(3):223-9. doi: 10.1053/euhj.2001.2738.

Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes.多支血管经皮血管重建术及替罗非班治疗急性冠脉综合征患者的疗效与安全性

Am J Cardiol. 2002 Sep 15;90(6):631-3. doi: 10.1016/s0002-9149(02)02569-9.

引用本文的文献

Acute Myocardial Infarction and Chronic Kidney Disease: A Nationwide Cohort Study on Management and Outcomes from 2010 to 2022.急性心肌梗死与慢性肾脏病：一项关于2010年至2022年管理与结局的全国性队列研究

Clin J Am Soc Nephrol. 2024 Oct 1;19(10):1263-1274. doi: 10.2215/CJN.0000000000000519. Epub 2024 Jul 18.

Impact of chronic kidney disease on case ascertainment for hospitalised acute myocardial infarction: an English cohort study.慢性肾脏病对住院急性心肌梗死病例检出的影响：一项英国队列研究。

BMJ Open. 2022 Mar 28;12(3):e057909. doi: 10.1136/bmjopen-2021-057909.

Relationship between serum cystatin-c and coronary lesion severity in coronary artery disease patients with a normal glomerular filtration rate.肾小球滤过率正常的冠心病患者血清胱抑素-C与冠状动脉病变严重程度的关系

J Int Med Res. 2021 Jan;49(1):300060520985639. doi: 10.1177/0300060520985639.

Contemporary National Outcomes of Acute Myocardial Infarction-Cardiogenic Shock in Patients with Prior Chronic Kidney Disease and End-Stage Renal Disease.既往慢性肾脏病和终末期肾病患者急性心肌梗死合并心源性休克的当代全国性结局

J Clin Med. 2020 Nov 18;9(11):3702. doi: 10.3390/jcm9113702.

Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry.慢性肾脏病程度对心肌梗死患者心脏治疗方法应用及预后的时间趋势变化：来自 NCDR 胸痛-MI 登记处的报告。

J Am Heart Assoc. 2018 Dec 18;7(24):e010394. doi: 10.1161/JAHA.118.010394.

Non-ST-Segment-Elevation Myocardial Infarction Among Patients With Chronic Kidney Disease: A Propensity Score-Matched Comparison of Percutaneous Coronary Intervention Versus Conservative Management.慢性肾脏病患者中的非 ST 段抬高型心肌梗死：经皮冠状动脉介入治疗与保守治疗的倾向评分匹配比较。

J Am Heart Assoc. 2018 Mar 10;7(6):e007920. doi: 10.1161/JAHA.117.007920.

Acute kidney injury requiring dialysis and in-hospital mortality in patients with chronic kidney disease and non-ST-segment elevation acute coronary syndrome undergoing early vs delayed percutaneous coronary intervention: A nationwide analysis.慢性肾脏病合并非ST段抬高型急性冠状动脉综合征患者早期与延迟经皮冠状动脉介入治疗后需要透析的急性肾损伤及院内死亡率：一项全国性分析

Clin Cardiol. 2017 Dec;40(12):1303-1308. doi: 10.1002/clc.22828. Epub 2017 Dec 20.

Comparison of 2-year clinical outcomes between diabetic versus nondiabetic patients with acute myocardial infarction after 1-month stabilization: Analysis of the prospective registry of DIAMOND (DIabetic acute myocardial infarctiON Disease) in Korea: an observational registry study.糖尿病与非糖尿病急性心肌梗死患者1个月病情稳定后2年临床结局的比较：韩国DIAMOND（糖尿病急性心肌梗死疾病）前瞻性注册研究分析：一项观察性注册研究

Medicine (Baltimore). 2016 Jun;95(25):e3882. doi: 10.1097/MD.0000000000003882.

How to balance risks and benefits in the management of CKD patients with coronary artery disease.如何在患有冠状动脉疾病的慢性肾脏病患者的管理中平衡风险与获益。

J Nephrol. 2015 Aug;28(4):403-13. doi: 10.1007/s40620-015-0184-2. Epub 2015 Feb 25.

Clinical features, use of evidence-based therapies, and cardiovascular outcomes among patients with chronic kidney disease following non-ST-elevation acute coronary syndrome.非ST段抬高型急性冠状动脉综合征后慢性肾脏病患者的临床特征、循证治疗的应用及心血管结局

Clin Cardiol. 2014 Jun;37(6):350-6. doi: 10.1002/clc.22253. Epub 2014 Jan 30.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验